A double-blind, randomized, homeopathic pathogenetic trial with healthy persons: Comparing two high potencies

Forschende Komplementarmedizin und Klassische Naturheilkunde

Volumn 11, Issue 5, 2004, Pages 274-280

  Mollinger H ^a,b   Schneider, R ^b   Loffel M ^c   Walach, H ^b  

^a Health Center Sokrates   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Heart Institute Lahr/Baden   (Germany)

Author keywords

Calendula officinalis; Ferrum muriaticum; Nonlocality; Pathogenetic trial; Placebo

Indexed keywords

CALENDULA EXTRACT; FERRUM MURIATICUM EXTRACT; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FERRUM MURIATICUM; HOMEOPATHY; HUMAN; INTERVIEW; MARIGOLD; MEDICINAL PLANT; NORMAL HUMAN; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; TELEPHONE; VOLUNTEER;

ADULT; CALENDULA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HOMEOPATHY; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PLACEBO EFFECT; PLANT EXTRACTS; PLANTS, TOXIC; TREATMENT OUTCOME;

EID: 10844238804     PISSN: 14247364     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082120     Document Type: Article

References (24)

1. Bleul G: Die Arzneimittelprüfung am Gesunden; in Bleul G (Hrsg): Weiterbildung Homöopathie. Band A: Grundlagen der Homöopathischen Medizin. Stuttgart, Johannes Sonntag, 1999.
2. Dantas F, Fisher PA: Systematic review of homoeopathic pathogenetic trials ('provings') published in the United Kingdom from 1945 to 1995; in Ernst E, Hahn EG (eds): Homoeopathy: A Critical Appraisal. London, Butterworth-Heineman, 1998, pp 69-97.
3. Kent JT: Repertory of the Homoeopathic Materia Medica. New Delhi, B. Jain, 1993.
4. Hahnemann S: Organon der Heilkunst. Heidelberg, Haug, 1999.
5. Sherr J: The Dynamics and Methodology of Homoeopathic Provings. West Malvern, England, Dynamics Books, 1994.
6. de Craen AJ, Tijssen JG, de Gans J, Kleijnen J: Placebo effect in the acute treatment of migraine: Subcutaneous placebos are better than oral placebos. J Neurol 2000;247:183-188.
7. Moerman DE, Jonas WB: Deconstructing the placebo effect and finding meaning response. Ann Intern Med 2002;136:471-476.
8. Vase L, Riley JL, Price DD: A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 2002;99:443-452.
9. Walach H: Placebo and placebo effects - a concise review. Focus Altern Complement Ther 2003;8: 178-187.
10. Walach H, Hieber S, Ernst-Hieber E: Effects of Belladonna 12 CH und 30 CH in healthy volunteers. A multiple, single-case experiment in randomisation design; in Bastide M (ed): Signs and Images. Dordrecht, Kluwer, pp 215-226.
11. Walach H: Does a highly diluted homoeopathic drug act as a placebo in healthy volunteers? Experimental study of Belladonna C30. J Psychosom Res 1993;37:860.
12. Walach H, Köster H, Henning T, Haag G: Effects of homeopathic Belladonna 30CH in healthy volunteers - a randomized, double-blind experiment. J Psychosom Res 2001;50:155-160.
13. Möllinger H: Fortlaufende, wissenschaftliche HAMP. Allg Hom Ztg 2000;3-19.
14. Jus MS: Amylenum nitrosum, Homöopathische Arzneimittelprüfung. Zug, Switzerland, Dr. B. K. Bose-Stiftung, 2001.
15. Riley DS: Nicotinamide adenine dinocleotide (NAD): a proving. J Am Inst Hom 1994;87:74-78.
16. Riley DS: Proving report - Veronica officinalis. BHJ 1995;84:144-148.
17. Deutscher Zentralverein homöopathischer Ärzte: Homöopathische Arzneimittelprüfung: Prinzipien, Durchführung, Deutung. Ergebnisse der Konsensuskonferenzen des DZhÄ 1998-2000. Köthen, Schriftenreihe des europäischen Instituts für Homöopathie (InHom), 2002.
18. Schroyens F: RADAR Synthesis (Software Version 8.1 2001). Belgium, Archibel S.A.
19. Milgrom LR: Patient-practitioner-remedy (PPR) entanglement. Part I: A qualitative, non-local metaphor for homeopathy based on quantum theory. Homeopathy 2002;91:239-248.
20. Milgrom LR: Patient-practitioner-remedy (PPR) entanglement. Part II: Extending the metaphor for homeopathy using molecular quantum theory. Homeopathy 2003a;92:35-43.
21. Milgrom LR: Patient-practitioner-remedy (PPR) entanglement. Part III: Refining the quantum metaphor for homeopathy. Homeopathy 2003b;92: 152-160.
22. Walach H, Sherr J, Schneider R, Shabi R, Bond A, Rieberer G: Homeopathic proving symptoms: Result of a local, nonlocal, or placebo process? A blinded, placebo-controlled pilot study (submitted).
23. Weingärtner O: Über die wissenschaftliche Bearbeitbarkeit der Identifikation eines «arzneilichen Gehalts» von Hochpotenzen. Forsch Komplementärmed Klass Naturheilkd 2002;9:229-233.
24. Walach H: Entanglement model of homeopathy as an example of generalized entanglement predicted by weak quantum theory. Forsch Komplementärmed Klass Naturheilkd 2003;10:192-200.